JP2024532158A5 - - Google Patents

Info

Publication number
JP2024532158A5
JP2024532158A5 JP2024509411A JP2024509411A JP2024532158A5 JP 2024532158 A5 JP2024532158 A5 JP 2024532158A5 JP 2024509411 A JP2024509411 A JP 2024509411A JP 2024509411 A JP2024509411 A JP 2024509411A JP 2024532158 A5 JP2024532158 A5 JP 2024532158A5
Authority
JP
Japan
Prior art keywords
seq
cil
amino acid
cfc
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024509411A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024532158A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/073147 external-priority patent/WO2023021171A1/en
Publication of JP2024532158A publication Critical patent/JP2024532158A/ja
Publication of JP2024532158A5 publication Critical patent/JP2024532158A5/ja
Pending legal-status Critical Current

Links

JP2024509411A 2021-08-20 2022-08-19 アトピー性皮膚炎を治療するためのホモ二量体融合タンパク質 Pending JP2024532158A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163235259P 2021-08-20 2021-08-20
US202163235261P 2021-08-20 2021-08-20
US63/235,261 2021-08-20
US63/235,259 2021-08-20
PCT/EP2022/073147 WO2023021171A1 (en) 2021-08-20 2022-08-19 Homodimer fusion proteins for treating atopic dermatitis

Publications (2)

Publication Number Publication Date
JP2024532158A JP2024532158A (ja) 2024-09-05
JP2024532158A5 true JP2024532158A5 (https=) 2025-08-22

Family

ID=83280140

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2024509411A Pending JP2024532158A (ja) 2021-08-20 2022-08-19 アトピー性皮膚炎を治療するためのホモ二量体融合タンパク質
JP2024509415A Pending JP2024532159A (ja) 2021-08-20 2022-08-19 アトピー性皮膚炎を治療するための融合タンパク質

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024509415A Pending JP2024532159A (ja) 2021-08-20 2022-08-19 アトピー性皮膚炎を治療するための融合タンパク質

Country Status (7)

Country Link
US (2) US20250325630A1 (https=)
EP (2) EP4388005A2 (https=)
JP (2) JP2024532158A (https=)
AU (2) AU2022331122A1 (https=)
CA (2) CA3227725A1 (https=)
MX (2) MX2024002148A (https=)
WO (2) WO2023021171A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025141037A1 (en) * 2023-12-28 2025-07-03 Elanco Animal Health Gmbh Il-4/il-13 and il-4/il-13/il-31 receptor trap constructs

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447233A (en) 1981-04-10 1984-05-08 Parker-Hannifin Corporation Medication infusion pump
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4447224A (en) 1982-09-20 1984-05-08 Infusaid Corporation Variable flow implantable infusion apparatus
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
EP0216846B2 (en) 1985-04-01 1995-04-26 Celltech Limited Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same
GB8601597D0 (en) 1986-01-23 1986-02-26 Wilson R H Nucleotide sequences
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
GB9818110D0 (en) 1998-08-19 1998-10-14 Weston Medical Ltd Needleless injectors and other devices
US6096002A (en) 1998-11-18 2000-08-01 Bioject, Inc. NGAS powered self-resetting needle-less hypodermic jet injection apparatus and method
US6703360B2 (en) 2000-04-07 2004-03-09 Heska Corporation Compositions and methods related to canine IgG and canine IL-13 receptors
US7696222B2 (en) 2005-08-12 2010-04-13 Merck Frosst Canada Ltd Indole derivatives as CRTH2 receptor antagonists
US7666622B2 (en) * 2005-10-19 2010-02-23 Regeneron Pharmaceuticals, Inc. Monomeric self-associating fusion polypeptides and therapeutic uses thereof
JP2010502224A (ja) * 2006-09-08 2010-01-28 アボット・ラボラトリーズ インターロイキン１３結合タンパク質
WO2009122748A1 (ja) * 2008-04-04 2009-10-08 国立大学法人九州大学 呼吸器系疾患又はアレルギー性疾患の治療剤
KR101335843B1 (ko) 2008-08-20 2013-12-02 조에티스 엘엘씨 피롤로[2,3-ｄ]피리미딘 화합물
US8637671B2 (en) 2008-09-22 2014-01-28 Merck Canada Inc. Indole derivatives as CRTH2 receptor antagonists
CA2736571A1 (en) 2008-09-22 2010-03-25 Merck Frosst Canada Ltd. Azaindole derivatives as crth2 receptor antagonists
WO2010031182A1 (en) 2008-09-22 2010-03-25 Merck Frosst Canada Ltd. Indole derivatives as crth2 receptor antagonists
CA2752981C (en) 2009-02-24 2013-11-12 Merck Sharp & Dohme Corp. Indole derivatives as crth2 receptor antagonists
KR101445012B1 (ko) 2009-12-17 2014-09-26 머크 샤프 앤드 돔 코포레이션 Ｓｙｋ 억제제로서의 아미노피리미딘
US8790651B2 (en) 2011-07-21 2014-07-29 Zoetis Llc Interleukin-31 monoclonal antibody
TWI682781B (zh) 2013-07-11 2020-01-21 美商再生元醫藥公司 藉由投與ｉｌ－４ｒ抑制劑治療嗜酸性食道炎的方法
CN106029697B (zh) 2013-12-20 2021-06-04 英特维特国际股份有限公司 具有经修饰的ch2-ch3序列的犬抗体
CA2980087A1 (en) 2015-04-02 2016-10-06 Intervet International B.V. Antibodies to canine interleukin-4 receptor alpha
JP7116063B2 (ja) 2016-12-14 2022-08-09 インターベット インターナショナル ベー． フェー． 選択的ヤヌスキナーゼ阻害剤としてのアミノピラゾール類
US10093731B2 (en) 2017-02-24 2018-10-09 Kindred Biosciences, Inc. Anti-IL31 antibodies for veterinary use
JP7657548B2 (ja) * 2017-04-21 2025-04-07 エランコ・ユーエス・インコーポレイテッド 獣医学的使用のためのｉｌ４／ｉｌ１３受容体分子
EP3480212B1 (en) * 2017-11-03 2023-09-27 Consejo Superior De Investigaciones Científicas Il13ralpha2 peptide and its uses
EP3870601A4 (en) 2018-10-25 2022-07-13 Kindred Biosciences, Inc. IL4/IL13 RECEPTOR MOLECULE FOR USE IN VETERINARY MEDICINE
US11548895B2 (en) 2019-04-24 2023-01-10 Elanco Us Inc. Process for making crystalline 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile

Similar Documents

Publication Publication Date Title
JP2024010112A5 (https=)
US5747254A (en) Promotion of high specificity molecular assembly
Urlaub et al. Sm protein–Sm site RNA interactions within the inner ring of the spliceosomal snRNP core structure
Kiehart et al. Cytoplasmic myosin from Drosophila melanogaster.
JP2013534812A5 (https=)
JP2021531826A5 (https=)
AU2023201726B2 (en) Il4/il13 receptor molecule for veterinary use
US12428466B2 (en) IL4/IL13 receptor molecule for veterinary use
JP2021511830A5 (https=)
JP2001511347A5 (https=)
JP2009537139A5 (https=)
JPH03204896A (ja) インターフェロンレセプター細胞外断片
JP2024516699A5 (https=)
JP2024532158A5 (https=)
US20240270819A1 (en) Il4/il13 receptor molecules for veterinary use
RU2007134568A (ru) Способы применения агонистов рецепторов гибели клеток и ингибиторов egfr
JP2024532159A5 (https=)
JP2023522676A5 (https=)
JP2017506505A5 (https=)
JP2004512010A5 (https=)
JP2023171909A5 (https=)
CN119451666A (zh) 用于基因编辑系统的脂质纳米颗粒
Arakawa et al. Solvent modulation of column chromatography
RU2024107064A (ru) Гомодимерные слитые белки для лечения атопического дерматита
Galindo et al. A third sea urchin sperm receptor for egg jelly module protein, suREJ2, concentrates in the plasma membrane over the sperm mitochondrion